"10.1371_journal.pone.0022293","plos one","2011-08-04T00:00:00Z","Christine A M Payan; François Viallet; Bernhard G Landwehrmeyer; Anne-Marie Bonnet; Michel Borg; Franck Durif; Lucette Lacomblez; Frédéric Bloch; Marc Verny; Jacques Fermanian; Yves Agid; Albert C Ludolph; Peter N Leigh; Gilbert Bensimon; on behalf of the NNIPPS Study Group","Département de Pharmacologie Clinique, Hôpital de la Pitié-Salpêtrière, APHP, UPMC Pharmacologie, Paris 6, UMR 7211, Paris, France; Service de Neurologie, Centre Hospitalier du pays d'Aix, Aix en Provence, France; Department of Neurology, University of Ulm, Ulm, Germany; Fédération de Neurologie, INSERM, Centre d'Investigation Clinique CIC9503, Hôpital de la Pitié-Salpêtrière, APHP & UPMC Université Paris 6, Paris, France; Service de Neurologie, Hôpital Pasteur, Nice, France; Service de Neurologie, Hôpital Gabriel Montpied, Clermont-Ferrand, France; Département de Neurologie, Hôpital de la Pitié-Salpêtrière, APHP, UPMC, Pharmacologie, Paris 6, INSERM, UMR-S 678, Paris, France; Centre de Gériatrie, Groupe Hospitalier Pitié-Salpêtrière & UPMC Université Paris 6, Assistance Publique-Hôpitaux de Paris, Paris, France; Service de Biostatistiques, Hôpital Necker-Enfants Malades, APHP, Paris, France; Clinical Neurosciences, Brighton and Sussex Medical School, Trafford Centre for Biomedical Research, University of Sussex, Falmer, United Kingdom","Conceived and designed the experiments: CAMP JF GB PNL ACL YA. Performed the experiments: FV BGL A-MB MB FD LL FB MV. Analyzed the data: CAMP GB JF. Contributed reagents/materials/analysis tools: FV BGL FD MB PNL MV GB. Wrote the paper: CAMP GB PNL JF.","Sanofi-Aventis affiliates in the UK, France and Germany provided an unconditional research grant and drug supply throughout the study. Sanofi-Aventis provided an unconditional research grant to fund the drug supply and data entry and to help with miscellaneous and travel expenses. Pr. F. Viallet reports personal compensation from GSK for speaking, from Novartis, Orkyn, Solvay, Servier, Teva-Lundbeck, Eisai for serving on a scientific advisory board and Boehringer as investigator in clinical trials. Dr. G.B. Landwehrmeyer, who serves on a scientific advisory board of Sienna Biotech, received funding from CHDI as research support. Dr. A.M. Bonnet serves as consultant for Medtronic-France. Dr. M. Borg received funding for research support from GSK and Novartis. Pr. F. Durif serves on scientific advisory boards for Novartis, Glaxo-SmithKline, Orkyn, Solvay, Servier, Teva-Lundbeck and Boehringer and receives research support from Novartis, Merz and Allergan. Dr. L. Lacomblez serves on scientific advisory boards for Novartis, Eisai and receives unrestricted research support from Glaxo-SmithKline, Novartis,Teva, Sanofi and Trophos. Pr. M. Verny serves on a scientific advisory board for Novartis and Eisai. Pr. J. Fermanian reports no disclosures. Pr. Y. Agid serves as consultant for Servier. Pr. A. C. Ludolph serves on Scientific Advisory Boards for Lundbeck, F. Hoffmann La Roche, Knopp Neurosciences. Received funding for travel expenses and/or honoraria for lectures from Boehringer-Ingelheim, Teva, ComtecMed, Lundbeck, Sanofi, ONO, Santhera, Schwarz Pharma, GlaxoSmithKline, Bayer Vital and Sanofi. Pr. P.N. Leigh has received payments for consultancy from GlaxoSmithKline, Acceleron pharma, NeuroNova, Trophos, and Teva and has received funding for clinical trials from GlaxoSmithKline, Teva, ONO Pharma, Trophos, and Sanofi-Aventis. Dr. G. Bensimon is presently a consultant for LTK-pharma, Allon pharma and TauRx pharma, and received funding for trial-related travel expenses from Sanofi-Aventis. Three academic institutions (Institute of Psychiatry, King's College London; Assistance Publique-Hôpitaux de Paris; and University of Ulm) were sponsors of the study in each country, and jointly own the data. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.","2011","08","Christine A M Payan","CAMP",15,TRUE,6,8,3,4,TRUE,TRUE,TRUE,1,"15",TRUE
